Studies have shown that epigenetic drugs can regulate the expression of immunological checkpoint molecules on TIL and tumor cells (134), such as Azacytidine upregulating the expression of PD-1 and PD-L1 in MDS/AML. This evidence concerns the gene PDCD1 and acute myeloid leukemia.